Evaluation of the effect of oral zinc in patients with chronic hemodialysis
Not Applicable
Completed
- Conditions
- Inflammation and malnutrition in patients with chronic hemodialysis.
- Registration Number
- IRCT20150706023084N5
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Hemodialysis patients consenting to participate in the study
Exclusion Criteria
Patients receiving tetracycline and quinolone.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie zinc's impact on inflammation and malnutrition in chronic hemodialysis patients?
How does oral zinc supplementation compare to standard-of-care treatments for inflammation and malnutrition in hemodialysis patients?
Which biomarkers are associated with response to zinc therapy in patients with chronic hemodialysis and inflammation?
What adverse events are commonly reported with zinc supplementation in hemodialysis patients and how are they managed?
Are there combination therapies involving zinc that improve outcomes for hemodialysis patients with malnutrition and inflammation?